Rossig, C., Juergens, H., Schrappe, M., Moericke, A., Henze, G., von Stackelberg, A., Reinhardt, D., Burkhardt, B., Woessmann, W., Zimmermann, M., Gadner, H., Mann, G., Schellong, G., Mauz-Koerholz, C., Dirksen, U., Bielack, S., Berthold, F., Graf, N., Rutkowski, S., Calaminus, G., Kaatsch, P. and Creutzig, U. (2013). Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria. Pediatr. Blood Cancer, 60 (10). S. 1574 - 1582. HOBOKEN: WILEY. ISSN 1545-5017

Full text not available from this repository.

Abstract

In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into nationwide disease-specific first-line clinical trials or interim registries. Essential components are a pediatric cancer registry and centralized reference laboratories, imaging review, and tumor board assistance. The five-year overall survival rate in countries where such infrastructures are established has improved from <20% before 1950 to >80% since 1995. Today, treatment intensity is tailored to the individual patient's risk to provide the highest chances of survival while minimizing deleterious late effects. Multicenter clinical trials are internationalized and serve as platforms for further improvements by novel drugs and biologicals. Pediatr Blood Cancer 2013;60:1574-1581. (c) 2013 Wiley Periodicals, Inc.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Rossig, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Juergens, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schrappe, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moericke, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Henze, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Stackelberg, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reinhardt, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Burkhardt, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Woessmann, W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zimmermann, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gadner, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mann, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schellong, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mauz-Koerholz, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dirksen, U.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bielack, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Berthold, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Graf, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rutkowski, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Calaminus, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kaatsch, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Creutzig, U.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-475619
DOI: 10.1002/pbc.24598
Journal or Publication Title: Pediatr. Blood Cancer
Volume: 60
Number: 10
Page Range: S. 1574 - 1582
Date: 2013
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1545-5017
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ACUTE LYMPHOBLASTIC-LEUKEMIA; HIGH-RISK NEUROBLASTOMA; CENTRAL-NERVOUS-SYSTEM; OF-PEDIATRIC-ONCOLOGY; LARGE-CELL LYMPHOMA; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; NON-HODGKINS-LYMPHOMA; BFM STUDY-GROUP; TERM-FOLLOW-UPMultiple languages
Oncology; Hematology; PediatricsMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/47561

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item